California Public Employees Retirement System Galectin Therapeutics Inc Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Aug 13, 2021	SELL	$2.07 - $5.1 $48,541 - $119,594	-23,450 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$1.67 - $2.3 $39,161 - $53,934	23,450	23,450 $50,000

Others Institutions Holding GALT

# of Institutions

Shares Held

9.69M

Call Options Held

1.16M

Put Options Held

1.98M

Vanguard Group Inc Valley Forge, PA

2.13M
Shares

$2.65 Million
0.0% of portfolio
Black Rock Inc. New York, NY

1.56M
Shares

$1.94 Million
0.0% of portfolio
Advisor Group Holdings, Inc. Phoenix, AZ

1.18M
Shares

$1.47 Million
0.01% of portfolio
Geode Capital Management, LLC Boston, MA

863K
Shares

$1.07 Million
0.0% of portfolio
Commonwealth Equity Services, LLC

483K
Shares

$599,247
0.0% of portfolio

View Full List

About GALECTIN THERAPEUTICS INC

Ticker GALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,426,000
Market Cap $73.7M
Description
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...

More about GALT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account